(75.101.220.230)
Users online: 3141    [ij] [ij] [ij] 
Email id
 

Asian Journal of Research in Pharmaceutical Science
Year : 2018, Volume : 8, Issue : 4
First page : ( 258) Last page : ( 260)
Print ISSN : 2231-5640. Online ISSN : 2231-5659.
Article DOI : 10.5958/2231-5659.2018.00043.7

A Study on Banned Drugs in India: A Review

Kengar Manohar D.*, Jagtap Ganesh B. Vambhurkar Asha M., Gavade Akshata S., Nitalikar Manojkumar M.

Rajarambapu College of Pharmacy, Kasegaon, Dist-Sangli, Maharashtra, India-415404

*Corresponding Author E-mail: manojkengar200@gmail.com

Online published on 25 December, 2018.

Abstract

The numbers of single drugs as well as fixed dose combinations drugs are banned in other countries but they have manufacturing, marketing and distribution in India. Over the counter availability of banned drugs sufficient adverse drug reactions data about these drugs have not been reported. The adverse effect of drugs is detected by regular monitoring after the drug released called pharmacovigilance. The Indian regulatory authority monitoring the new drug in market before pre-clinical study and permit to sold in market. The banned dugs prescribed over the counter the responsible as unawareness of physicians and patients, poverty, self-medication, carelessness of regulatory authorities, non availability of appropriate drugs, high cost, and communication. The Government of India is in the process of developing a regulatory regime designed to ensure the quality, safety and performance of medical devices.

Top

Keywords

Banned Drug, Indian Drug, FDA, Adverse drug reaction, Pharmacovigilance.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
446,304,378 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.